The innate immune response of airway epithelial cells to airborne allergens initiates the development of T cell responses that are central to allergic inflammation. Although proteinase allergens induce the expression of interleukin 25, we show here that epithelial matrix metalloproteinase 7 (MMP7) was expressed during asthma and was required for the maximum activity of interleukin 25 in promoting the differentiation of T helper type 2 cells. Allergen-challenged Mmp7 -/-mice had less airway hyper-reactivity and production of allergic inflammatory cytokines and higher expression of retinal dehydrogenase 1. Inhibition of retinal dehydrogenase 1 restored the asthma phenotype of Mmp7 -/-mice and inhibited the responses of lung regulatory T cells, whereas exogenous administration of retinoic acid attenuated the asthma phenotype. Thus, MMP7 coordinates allergic lung inflammation by activating interleukin 25 while simultaneously inhibiting retinoid-dependent development of regulatory T cells.
The innate immune response of airway epithelial cells to airborne allergens initiates the development of T cell responses that are central to allergic inflammation. Although proteinase allergens induce the expression of interleukin 25, we show here that epithelial matrix metalloproteinase 7 (MMP7) was expressed during asthma and was required for the maximum activity of interleukin 25 in promoting the differentiation of T helper type 2 cells. Allergen-challenged Mmp7 -/-mice had less airway hyper-reactivity and production of allergic inflammatory cytokines and higher expression of retinal dehydrogenase 1. Inhibition of retinal dehydrogenase 1 restored the asthma phenotype of Mmp7 -/-mice and inhibited the responses of lung regulatory T cells, whereas exogenous administration of retinoic acid attenuated the asthma phenotype. Thus, MMP7 coordinates allergic lung inflammation by activating interleukin 25 while simultaneously inhibiting retinoid-dependent development of regulatory T cells.
Proximal and distal airway epithelial cells directly communicate with the outside environment, and thus their response to inhaled allergens could be integral to the initiation of allergic lung inflammation. Identification of the critical epithelium-derived mediators that drive allergic lung responses is at an early stage but is essential to complete understanding of the molecular mechanisms that underlie diseases such as asthma. After being inhaled, proteinase allergens (such as airborne allergens with active proteinase properties) rapidly induce a powerful inflammatory response that initiates the recruitment of allergic immune cells into the lung 1, 2 . Although the function of cytokines expressed in the airway epithelium in asthma has been studied extensively 3, 4 , the mechanism by which allergens initiate the differentiation of airway T helper type 2 (T H 2) cells is poorly understood. Interleukin 25 (IL-25; also called IL-17E) is a member of the IL-17 family of cytokines that is produced mainly in the airway epithelium in response to proteinase allergens 5, 6 . Transgenic expression of human and mouse IL-25 induces T H 2 immune responses marked by considerable lung eosinophilia, mucus hyperproduction and higher expression of IL-4, IL-5, IL-13 and CCL11 (eotaxin 1) in the airway 7, 8 . Neutralization of IL-25 by blocking antibodies has been shown to reverse airway hyper-reactivity, a pathognomonic feature of asthma, in a mouse model of asthma 9 . Moreover, IL-25-deficient mice are unable to develop a strong T H 2-biased immune response and fail to clear gut parasitic infection with Nippostrongylus brasiliensis or Trichuris muris 10 . Such studies suggest a critical function for epithelial cells in providing the IL-25 signals that may be required for effective T H 2 responses. Although the function of IL-25 in allergic lung disease is well known, a broader understanding of how IL-25 interacts with other airway epithelial factors to coordinately regulate allergic responses is needed.
Matrix metalloproteinases (MMPs) are zinc-dependent enzymes that are induced in response to many stimuli. Although MMPs were originally shown to mediate the turnover of extracellular matrix molecules, it is now apparent that they control diverse biological processes unrelated to matrix degradation 11 . Although the exact function of MMPs in chronic models of lung inflammation is debatable, it is clear that several members of this family are acutely induced either locally or systemically at the onset of allergen challenge [12] [13] [14] [15] [16] . MMP2 and MMP9 are not required for the development of allergic lung disease but serve key functions in the clearance of inflammatory cells from lung parenchyma by establishing the necessary trans-epithelial chemokine gradients 15, 16 . However, whereas neither MMP2 nor MMP9 is expressed in the airway epithelium 17 , MMP7 (also called matrilysin; A001477), an epithelial cell-specific MMP, is induced in the lung and gut during inflammation 18, 19 . MMP7 has been shown to modify pro-a-defensin, the ligand for the cell surface receptor Fas (FasL; CD95L) and tumor necrosis factor in the gut during defense against enteric pathogens, but its function in allergic inflammation has yet to be explored 19, 20 .
In this study, we examine how airway epithelial IL-25 coordinates proteinase-dependent allergic lung disease in the context of other potentially relevant airway epithelium-derived factors, including MMP7. We show that in response to proteinase allergen or recombinant IL-25 (rIL-25), mouse airway epithelial cells expressed MMP7. Activation of MMP7 was critical for IL-25 function because MMP7-cleaved rIL-25 (called 'rIL-25'C' here) enhanced T H 2 differentiation. Furthermore, we show that humans with chronic asthma also expressed MMP7 and IL-25 in their distal airspaces and, in response to ragweed extract, a potent allergenic stimuli, patients with a history of allergy had significantly more nasal secretion of MMP7. In the absence of MMP7, mice showed attenuated allergic responses to challenge with proteinase allergen and enhanced expression of retinal dehydrogenase 1 (RALDH-1), a rate-limiting enzyme for the production of retinoic acid. Moreover, Mmp7 -/-mice had more regulatory T cells in the lung parenchyma. Our results collectively support the idea that MMP7 serves as a proinflammatory mediator that specifically enhances the function of IL-25 that is necessary for robust T H 2 responses. Finally, we demonstrate a tolerogenic mechanism initiated by airway epithelial cells in response to challenge with proteinase allergen in which RALDH-1 was induced to promote immunosuppressive regulatory T cells.
RESULTS

MMP7 mediates enhanced function of IL-25
MMP2 and MMP9 are not expressed in airway epithelial cells after allergen challenge 17 . In contrast, we found that a fungus-derived proteinase allergen strongly enhanced airway epithelial expression of MMP7 (Fig. 1a) . Whereas induction of MMP2 and MMP9 is IL-13 dependent 15 , MMP7 induction was independent of IL-13, as there was equivalent induction of MMP7 in wild-type mice and allergenchallenged mice deficient in STAT6, the principal mediator of the effects of IL-13 in the lung (data not shown). Because MMP7 is known to cleave and activate cytokines in the gut 13 , we next determined if MMP7 modifies cytokines critical for initiating allergic lung responses. In addition to IL-25, both IL-13 and thymic stromal lymphopoietin (TSLP) are critical participants in the molecular pathways that underlie allergic lung disease 5, 21 . We found that although rIL-13 and rTSLP were not substrates for activated MMP7, in the same conditions, rIL-25 was cleaved at multiple sites ( Fig. 1b and Supplementary Table 1 and Fig. 1 online) . To determine the function of cleaved IL-25, we examined the responses of naive spleen and lymph node cells after activation by crosslinking of T cell antigen receptors in vitro. We found that rIL-25'C induced significantly more secretion of T H 2 cytokines (IL-4, IL-5 and IL-13) than did native rIL-25 and it showed enhanced binding to a fusion protein of IL-17 receptor B and the Fc fragment in vitro (Fig. 1c,d and Supplementary Fig. 2a,b online) . Indeed, native IL-25 had little effect on IL-4 secretion, but rIL-25'C enhanced IL-4 secretion tenfold, which suggested that the main active form of IL-25 is the MMP7-cleaved form. We found no effect of rIL-25 or rIL-25'C on the induction of interferon-g, a canonical T H 1 cytokine (Fig. 1c) . Collectively, these data indicate that IL-25 is a substrate for MMP7 and that cleavage of IL-25 by MMP7 is needed to drive robust T H 2 responses. of Mmp7 -/-and wild-type mice to the proteinase allergen CAA (complete aspergillus allergen) extracted from fungi, a powerful allergen used before to elicit allergic lung disease in mice 1 . This airway inflammation model is characterized by a predominantly eosinophilic influx and airway obstruction due to enhanced glycoprotein secretion, as well as more airway hyper-reactivity to secondary challenge with acetylcholine 22, 23 . Mmp7 -/-mice immunized with CAA had less airway hyper-reactivity than did wild-type mice, as shown by both their lower respiratory system resistance in response to many doses of acetylcholine and higher stimulating concentration of acetylcholine required to elicit a 200% change from the baseline respiratory system resistance. Moreover, Mmp7 -/-mice had less secretion of glycoproteins in bronchoalveolar lavage (BAL) fluid after CAA challenge ( Fig. 2a-c) .
Airway eosinophilia was also significantly lower in CAA-immunized Mmp7 -/-mice (Fig. 2d) . Because the egress of lung parenchymal eosinophils into the airways is impaired in Mmp2 -/-and Mmp9 -/-mice 15, 16 , we assessed lung parenchymal eosinophils to rule out the possibility of a similar defect in Mmp7 -/-mice. Analysis of the total number of lung parenchymal inflammatory cells showed that the lungs of CAA-immunized Mmp7 -/-mice had fewer eosinophils than did those of wild-type mice ( Fig. 2e and Supplementary Fig. 3 online), which indicated that the lower cell number in the airway was not due to less cell trafficking.
We next assessed whether MMP7-mediated modification of IL-25 was influential in determining allergic lung responses. We administered rIL-25 intranasally to wild-type and Mmp7 -/-mice and assessed eosinophil recruitment. In this assay, rIL-25 alone readily induced lung eosinophilia and new expression of MMP7 in airway epithelial cells of wild-type mice, but we found significantly fewer eosinophils and lower concentrations of IL-4 and IL-5 in the BAL fluid of Mmp7 -/-mice (Fig. 2f,g and Supplementary Fig. 4 online). Collectively, these findings support the idea that induction of MMP7 in response to allergens is critical for enhancing IL-25 function during initiation of the allergic immune response.
Diminished T H 2 responses of Mmp7 -/-mice
We next determined if the diminished airway hyper-reactivity and BAL inflammatory cells in Mmp7 -/-mice were secondary to lower T H 2 responses in Mmp7 -/-mice. As expected, CAA-challenged Mmp7 -/-mice had less IL-4, IL-5, IL-13, IL-6 and tumor necrosis factor in BAL fluid than did wild-type mice (Fig. 3a-c and Supplementary Fig. 5 online), whereas we found no significant differences in the concentrations of CCL3, IL-9 and IL-1b (data not shown). Consistent with the diminished lung eosinophilia, we found significantly lower CCL11 expression in CAA-immunized Mmp7 -/-mice than in CAA-immunized wild-type mice, but we detected no significant differences the concentrations of CCL7 and CCL17 (Fig. 3d , and data not shown). Furthermore, whole-lung analysis of RNA showed that immunized Mmp7 -/-mice had lower expression of Il25 than did wild-type mice (Fig. 3e) , which suggested that in addition to proteolytic modification of IL-25, activation and function of MMP7 in the lung is required for the transcriptional expression of Il25 in this model of allergic airway disease.
Mmp7
More retinoic acid in allergen-challenged Mmp7 -/-mice To identify additional events that might regulate the airway epithelial response to allergen, we did proteomic analyses of BAL fluid from CAA-immunized wild-type and Mmp7 -/-mice 17 . Among the proteins that were significantly and differently modulated in CAA-immunized Mmp7 -/-mice (P o 0.05; Supplementary Table 2 online), we found that they had more RALDH-1 (Fig. 4a,b and Supplementary Fig. 6 online). RALDH-1 is the rate-limiting enzyme for the conversion of retinaldehyde to all-trans retinoic acid (ATRA), which is critical for maintenance of the tolerogenic environment of mucosal surfaces 24 . In support of our proteomic-based finding of more RALDH-1, analysis of BAL fluid showed that CAA-immunized Mmp7 -/-mice had a higher ATRA concentration than did CAA-immunized wild-type mice (Fig. 4c) . Next, we determined if more production of ATRA in the lungs of Mmp7 -/-mice might account in part for their attenuated response to allergen. We delivered liposomal ATRA by means of respiratory aerosol to wild-type mice 1 h before each immunization with CAA, then assessed lung allergic responses. Mice that received ATRA had an attenuated asthma phenotype, as demonstrated by fewer total cells in BAL fluid, especially eosinophils, and lower expression of Il25 mRNA than that of mice given aerosol vehicle (empty liposome; Fig. 4d-f) . Time (min) Consistent with lower expression of inflammatory markers, we also detected less CCL11, IL-4 and IL-13, which act 'downstream' of IL-25 signaling (Fig. 4g-i and Supplementary Fig. 7 online) . These data confirm that ATRA has potent anti-inflammatory activity when administered to the lung and that this activity can be enhanced through inhibition of Il25 expression.
Epithelial RALDH-1 and ATRA induce regulatory T cells
We found expression of RALDH-1 protein in airway epithelial cells and alveolar macrophages of CAA-immunized wild-type and Mmp7 -/-mice (Fig. 5a ). Higher expression of RALDH-1 and concentrations of ATRA have been linked to enhanced immune tolerance and more production of inducible regulatory T cells 25 . Therefore, we determined if higher expression of RALDH-1 acted as a negative regulator in response to allergens and increased the abundance of regulatory T cells in the lungs of wild-type and Mmp7 -/-mice after immunization with CAA. CAA-immunized wild-type and Mmp7 -/-mice had more CD25 + Foxp3 + regulatory T cells in lungs than did naive mice ( Fig. 5b and Supplementary Fig. 8 online) . To further examine the function of RALDH-1 in inducing the production of regulatory T cells, we administered citral, an inhibitor of RALDH-1, to mice immunized with CAA 26 . Inhibition of the synthesis of retinoic acid by citral resulted in fewer CD25 + Foxp3 + regulatory T cells in the lung (Fig. 5b and Supplementary Fig. 9 online) , which suggested possible involvement of RALDH-1 and ATRA in the development of this inhibitory subset of lung T cells. Moreover, wild-type and Mmp7 -/-mice immunized with CAA and challenged with citral had more eosinophils, IL-5 and CCL11 in BAL fluid than did mice immunized with CAA alone (Fig. 5c-e and data not shown).
MMP7 expression in response to allergen in human asthma
To address the relevance of MMP7 expression to human asthma, we studied bronchial biopsy specimens from human volunteers with and without asthma. Notably, whereas we detected IL-25 in airway epithelia of subjects with and without asthma and thus it seemed to be constitutively present, we found MMP7 expression exclusively in the airways of asthmatic subjects (Fig. 6a) . Consistent with those findings, analysis of nasal washings collected from volunteers with allergic rhinitis 30 min and 5 h after intranasal challenge with ragweed (a potent proteinase allergen) showed significantly more MMP7 secretion in response to ragweed (Fig. 6b) but not in response to the normal saline control (data not shown). We did not detect secretion of IL-25 in nasal washes. Nonetheless, these data suggest that constitutive IL-25 was activated by inducible expression of MMP7 during allergen challenge of the human airway.
DISCUSSION
We have shown here how proteinase allergens simultaneously activated pro-and anti-inflammatory programs in airway epithelial cells. Allergens enhanced MMP7 expression in airway epithelial cells to maximize allergic lung inflammation; conversely, in the absence of MMP7, mice developed an attenuated asthmatic phenotype. The mechanisms responsible for the diminished allergic inflammation in Mmp7 -/-mice seemed to be in part related to lower expression of IL-25, which has been shown to be critical in initiating robust T H 2 responses 5, 7, 27, 28 . We found that in addition to modulating Il25 expression, MMP7 mediated IL-25 cleavage that was required for most of the biological activity of IL-25 in allergic inflammation. Enhanced expression of MMP family members is a frequent manifestation of active or chronic inflammatory process, but the precise function of MMPs in these conditions remains poorly understood 13 . Studies have documented that proteinase allergens are able to induce an innate immune response that further modulates the adaptive immune response during allergic inflammation 1, 2 . We have shown here that airway epithelial expression of MMP7 was critical for the development of asthma-like disease, a finding in contrast to the functions of MMP2 and MMP9, two gelatinases that are also upregulated in the same model, as absence of these enzymes leads to exaggerated lung allergic inflammation [15] [16] [17] . Furthermore, we have shown that MMP7 was expressed in the distal lung parenchyma of untreated asthmatics and that in response to a proteinase allergen derived from ragweed, MMP7 expression was significantly induced. Although the secretion of IL-25 in the same conditions was below the detection limit of our enzyme-linked immunosorbent assay (ELISA), we found IL-25 expression in the distal lung space in normal and asthmatic volunteers.
Collectively, these findings demonstrate a temporal relation between exposure to allergens and induction of MMP7 in human allergic disease and may indicate involvement of activation of IL-25 by MMP7 in conditions of allergen exposure. It is important to note that during allergic inflammation, many endogenous proteinases, including members of the serine and cysteine family, are abundantly present in the airway 1, 29 . However, our finding that MMP7 was required for the amplification of T H 2 responses emphasizes the nonredundant functions that MMPs may serve in the course of inflammation. The specificity of this response was exemplified by the specific proteolysis of IL-25, but not of other allergy-related cytokines such as TSLP and IL-13, by MMP7. Similarly, MMP7-mediated proteolytic modification of defensins, apoptotic ligands and cytokines has been shown to be important in diverse biological functions, such as innate immunity in the gut to cancer cell metatasis 19, [30] [31] [32] . The findings that rIL-25 induced expression of lung MMP7 and intranasal administration of rIL-25 to Mmp7 -/-mice only weakly induced allergic inflammation suggest that the bioactivity of IL-25 depends mainly on proteolysis by MMP7. These data further suggest the existence of a feedback loop in which IL-25 upregulates lung MMP7 expression, followed by cleavage and activation of IL-25 that further enhances both MMP7 expression and allergic lung disease.
Although regulation of gene expression has been studied for other members of the IL-17 family, little is known about IL-25 regulation 12 . We found that although there was little or no RALDH-1 in the airways of naive mice, this enzyme had prominent expression in the airway epithelial cells of both wild-type and Mmp7 -/-mice in response to a proteinase allergen. By high-throughput proteomic analysis, we found excess RALDH-1 enzyme in CAA-immunized Mmp7 -/-mice that was functionally relevant because it resulted in higher BAL fluid concentrations of ATRA and less allergic inflammation. The function of ATRA in the regulation of adaptive immunity, especially T H 2 responses, is controversial. For example, IL-4-induced eotaxin production, eosinophil lineage commitment and IL-5 receptor expression are all inhibited by the addition of ATRA in vitro 33, 34 . Furthermore, retinoic acid in the presence of transforming growth factor-b1 inhibits the binding of STAT6 to the promoter of the gene encoding the transcription factor Foxp3 and effectively inhibits IL-4 signaling in T cells 35 . In other models of allergic lung disease, deficiency in vitamin A results in lower expression of the muscarinic M2 receptor, which results in more airway hyper-reactivity 36 . In contrast, intranasal administration of high concentrations of ATRA (over 1,500 mg) has been shown to fail to alter T H 2 responses in another asthma model 37 , and vitamin A deficiency has been shown to attenuate the production of T H 2 cytokines in mice 38 . In our study, allergen-challenged mice that received 100 mg ATRA showed much lower allergic inflammation and attenuation of the asthmatic phenotype. Such divergent findings are not unexpected, given the known idiosyncrasies of retinoid, which can act as a hormone and, depending on the physiological or pharmaceutical context, can mediate diverse effects on cells of the immune system 39 .
Studies have indicated involvement of ATRA in the development and differentiation of inducible regulatory T cells, an antiinflammatory subset of T cells that are important in the homeostasis of lymphocytes in various organs 40 . In particular, dendritic cells in the lamina propria have been found to provide ATRA that is critical for the differentiation of regulatory T cells and homing of these cells to the intestinal mucosa 41, 42 . Although we did not identify the cellular origin of ATRA, we found that RALDH-1, the rate-limiting enzyme that converts retinaldehyde to ATRA, was upregulated in response to allergic stimulation in the airway epithelium, which indicates a possible site for ATRA production in the lung. Consistent with the requirement for ATRA in the differentiation of regulatory T cells in vivo 25, 41, 43 , we found more CD25 + Foxp3 + T cells in the lungs of Mmp7 -/-mice immunized with CAA than in the lungs of CAA-immunized wild-type mice. Moreover, we found that inhibition of the synthesis of retinoic acid by citral inhibited the development of regulatory T cells. The higher percentage of regulatory T cells after allergen challenge in both wild-type and Mmp7 -/-mice suggested that RALDH-1 is a negative regulator of allergic inflammation, a plausible protective response regulated by airway epithelial cells that we found to be enhanced in the absence of MMP7. What remains unclear is the mechanism responsible for the higher expression and function of RALDH-1 in the lung in the absence of MMP7. Our finding of RALDH-1 expression in airway epithelial cells and macrophages in response to allergen challenge is in agreement with published reports indicating an anti-inflammatory function for these cells in allergic inflammation 44 . Furthermore, depletion of alveolar macrophages results in an exaggerated allergic response that can be inhibited by adoptive transfer of alveolar macrophages in brown Norway rats 45 . Our data suggest that alveolar macrophages that mediate antiinflammatory responses during allergic inflammation might be acting through RALDH-1, an idea that is also consistent with the tolerogenic function of RALDH-1 in gut lamina propria 41, 42 .
In summary, we have described here a proinflammatory function of MMP7 that was activated in response to proteinase allergens and involved proteolytic modification of the expression and function of IL-25. In this model, we found activation of RALDH-1 was 'downstream' of allergen-induced inflammation and that MMP7 actively inhibited the function of this enzyme in vivo. This unique mechanism involved, at least in part, inhibition of regulatory T cells that inhibit lung inflammation. Our findings thus substantially expand the understanding of the regulation of IL-25, a critical innate cytokine in allergic responses, and further identify pro-and anti-inflammatory targets that can be explored for therapeutic benefit. Experimental model of asthma. CAA, composed of Aspergillus oryzae proteinase (1 mg/ml; Sigma) and ovalbumin (0.5 mg/ml; Sigma) in a volume of 50 ml, was administered intranasally every 4 d for a total of five doses as described before 1, 16 . In some experiments, rIL-25 (5 mg in 50 ml PBS) was administered intranasally twice daily for 3 d. In some experiments, liposomal ATRA or citral was given by aerosol administration 1 h before CAA challenge. Additional information on the liposome formulation and administration of ATRA is in the Supplementary Methods.
Experimental ragweed allergen challenge in human volunteers. Nasal 'provocation' with ragweed pollen extract was done as described 46 . The Institutional Review Board at the University of Texas Medical Branch reviewed and approved the protocol and consent forms. The challenge procedure and analysis of nasal lavage fluid and bronchial biopsies are described in the Supplementary Methods. Analysis of asthmatic phenotype. All data were collected 24 h after the final allergen challenge. Airway hyper-reactivity was assessed by estimation of the concentration of acetylcholine (in mg per g body weight) that caused a 200% increase in airway resistance over the baseline, calculated by linear interpolation of the appropriate dose-response curves as described 15 . Collection and analysis of BAL fluid and lung tissue is described in the Supplementary Methods.
Immunohistochemistry. A standard published protocol was used for immunohistochemistry 47 . Deparaffinized sections were washed with 3% (vol/vol) H 2 O 2 and 2% (vol/vol) Triton X-100 in PBS, followed by antigen retrieval (Target Retrieval Solution; Dako). Slides were incubated overnight at 4 1C with rabbit polyclonal antibody to mouse ALDH1A1 (24343; Abcam), rat monoclonal antibody to mouse MMP7 (377314; R&D Systems), mouse monoclonal antibody to human MMP7 (377314 (R&D Systems) or ID2 (Calbiochem)) and mouse monoclonal antibody to human IL-17E. Additional information on staining and analysis is in the Supplementary Methods.
Measurement of cytokines and chemokines in BAL fluid. CCL11, CCL7 and CCL17 in BAL fluid were measured by standard antibody-based ELISA and/or a multiplex bead-based cytokine detection kit (BioRad) as described 16 . Reagents and the LINCOplex assay are described in the Supplementary Methods. Proteomics analysis of BAL protein. Proteomics analysis of BAL fluid was done as described 17 . BAL samples from wild-type and Mmp7 -/-mice were pooled and were concentrated with AMICON filters, and protein concentrations were measured by BCA protein assay (bicinchoninic acid; Pierce). An equal amount of protein from each pooled sample (50 mg) was labeled with 400 pmol fluorescent dye (CyDye; Amersham Biosciences) matched by charge and molecular size and was brought to a final volume of 250 ml with sample buffer that also contained 0.5% (wt/vol) ampholytes (pH 3-11, nonlinear), 0.1% (wt/vol) bromophenol blue and DeStreak reagent (12 ml/ml; GE Healthcare). Additional information on proteomics analysis is in the Supplementary Methods.
Quantitative RT-PCR. The RNeasy mini kit (Qiagen) was used for extraction of total cellular RNA from mouse lung tissues stabilized with the RNA Later reagent (Qiagen). One-step real-time quantitative RT-PCR (Real-Time PCR system 7300; Applied Biosystems) was used to assess the expression of Ccl11 (encoding CCL11 (eotaxin 1)) and Aldh1a1 (encoding RALDH-1). The primer and probe mixtures of target genes (Ccl11, Mm00441238_m1; Raldh-1, Mm01194995_mH; Applied Biosystems identifiers) and 18S rRNA were from Applied Biosystems. Additional information on RT-PCR is in the Supplementary Methods.
MMP activation and in vitro cleavage assay. Carrier-free mouse rIL-25 (5 mg; R&D), mouse rIL-13 (Peprotech) and mouse rTSLP (R&D Systems) were incubated for 2 h at 37 1C with 0.5 mg 4-aminophenylmercuric acetate-activated MMP7 in the presence or absence of the MMP inhibitor 1,10-phenanthroline (10 mM; Sigma). After incubation, equal volumes of each sample (16.5 ml) were reduced and were resolved by separation through a 16.5% tricine gel. Cleaved and uncleaved proteins were visualized with the Proteosilver Plus Silver Stain kit according to the manufacturer's instructions (Sigma-Aldrich). Additional information on these assays is in the Supplementary Methods. Amino-terminal sequencing of IL-25 was done by standard protein-sequencing methods (Procise 492cLC; Applied Biosystems).
Cell culture. Lymph node cells and splenocytes isolated from C57BL/6 mice were stimulated with plate-bound antibody to CD3 (anti-CD3; 2 mg/ml) and human IL-2 (50 U/ml) in the presence of mouse rIL-25 (250 ng/ml; R&D Systems) or rIL-25'C (250 ng/ml). After 2 d, culture supernatants were collected and analyzed for IL-4, IL-5, IL-13 and interferon-g by ELISA as described 5 . On day 3, cells were restimulated for 5 h with ionomycin (500 ng/ml) and phorbol 12-myristate 13-acetate (50 ng/ml) in the presence of GolgiStop (BD Biosciences). Cells were made permeable with a Cytofix/Cytoperm kit (BD Biosciences) and were analyzed for intracellular expression of IL-4 (with phycoerythrin-conjugated anti-IL-4; 11B11) and IL-5 (with allophycocyaninconjugated anti-IL-5; TRFK5; both from BD Biosciences).
Flow cytometry. Total lung eosinophils were quantified by bead-enhanced flow cytometry as described 48 . Total mouse lung cells were stained with fluorescein isothiocyanate-conjugated conjugated antibody to major histocompatibility class II (2G9; 553623; BD Biosciences) and phycoerythrin-conjugated antiSiglec-F (1 mg per 10 6 cells; E50-2440; BD Biosciences), followed by incubation with fluorescent beads (Flow-Check Fluorospheres; Beckman Coulter). Samples were acquired with a flow cytometer (XL2; Beckman Coulter) and cell and bead counts were measured. Absolute numbers of eosinophils were calculated with formulas as described 48 . Additional information on flow cytometry is in the Supplementary Methods.
High-performance liquid chromatography (HPLC). Pooled BAL samples from wild-type and Mmp7 -/-mice were evaporated under nitrogen and the dry residue was dissolved in 100 ml acetonitrile (Fisher). Aliquots of 25 ml were then analyzed with the Waters HPLC system, consisting of a WISP autosampler (model 717 Plus), dual-absorbance detector (model 2487), pump (model 515) and Nova-Pak C18 columns (3.9 mm Â 150 mm). ATRA was separated with a solvent system of 57.5% (vol/vol) acetonitrile, 25% (vol/vol) acetic acid (2% solution) at a flow rate of 1.3 ml/min. Data were analyzed with Waters Millennium software (version 3.2).
Binding assay. Analysis of the binding of IL-25 to the fusion protein of IL-17 receptor B and Fc fragment is described in the Supplementary Methods. 
